MIT’s decade-plus pitch to embed microchip-based drug-dispensaries in humans has been re-framed as a microprocessor-based, wireless-controlled, fully Internet-of-Things-compliant, implantable contraceptive.
Since 1999, MIT’s Robert Langer et al have been pitching the idea of using microchips to deliver medicines. The idea, way back then, was envisaged chips with reservoirs of drugs kept behind a gold membrane. Applying a voltage to the membrane would dissolve it to release the liquid.
Perhaps because healthcare is one of the world’s most regulated research fields, it took from 1999 to 2006 for MicroCHIPS (the company set up to commercialise the technology and manage the patent portfolio) to get through its pre-clinical work, according to the Boston Business Journal.
That was followed up with its first clinical trial, which was completed in 2012, testing dispensing osteoarthritis medications.
via The Register
July 9, 2014